This study elucidates the specific Gq/PLC/IP3/calcium-calmodulin intracellular signaling pathway by which angiotensin II depresses baroreflex function in the NTS, providing mechanistic insights relevant to heart failure and hypertension.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for baroreflex-targeted therapies in hypertension or HF; extends mechanistic insights into NTS ANG II signaling but needs human validation.
Heart failure and hypertension are associated with increases in angiotensin II (ANG II) activity. One brain area where ANG II effects may be particularly important in these situations is the nucleus of the solitary tract (NTS). Located in the dorsomedial medulla, the NTS is the termination site of baroreceptor afferents and is essential for mediating the baroreflex. In hypertensive animals the baroreflex is impaired; this may be reversed by antagonizing ANG II AT1 receptors in the NTS. Recently, we showed that the baroreflex depressant action of ANG II in the NTS is mediated by activation of endothelial nitric oxide synthase (eNOS) and enhanced release of GABA. Using conventional pharmacological tools and a range of adenoviral-mediated expression of dominant negative proteins, we have determined the intracellular pathway(s) in the NTS by which ANG II activates eNOS. Our data indicate that ANG II acting in the NTS depresses the baroreflex via a Gq protein-mediated activation of phospholipase C, which through 1,4,5-inositol triphosphate causes release of calcium from the IP3-sensitive intracellular stores and calcium-calmodulin formation. In contrast, multiple site disruption of a pathway leading to eNOS activation via the serine/threonine kinase Akt was ineffective
No takes yet. Share an insight, caveat, or question.
Wong et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: